QSAR studies may help to better understand structural requirements for peptide bioactivity and therefore to develop potent BAPs.
No takes yet. Share an insight, caveat, or question.
Nongonierma et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: